Krashaemodes 8000 (Solution) Instructions for Use
Marketing Authorization Holder
Kraspharma, PJSC (Russia)
ATC Code
B05AA (Blood substitutes and plasma preparations)
Dosage Form
| Krashaemodes 8000 | Infusion solution: 100 ml, 200 ml or 400 ml bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Infusion solution | 100 ml |
| Povidone (low molecular weight medical polyvinylpyrrolidone) with molecular weight 8000±2000 | 6 g |
| Sodium chloride | 550 mg |
| Potassium chloride | 42 mg |
| Calcium chloride | 50 mg |
| Sodium bicarbonate | 23 mg |
| Magnesium chloride anhydrous | 500 mcg |
100 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Drug with detoxifying action for parenteral use
Pharmacotherapeutic Group
Detoxifying agent
Pharmacological Action
The action of the combination is due to the ability of low molecular weight polyvinylpyrrolidone to bind toxins circulating in the blood and rapidly remove them from the body. It most fully binds toxins circulating in the blood of patients with dysentery, salmonellosis, and food intoxications. In burn disease, toxins formed during the first 4-5 days of the disease are almost completely inactivated; toxins formed at later stages are neutralized significantly weaker.
Toxins formed in the body of patients with acute radiation sickness are not bound, although their elimination from the body may be accelerated.
It helps eliminate erythrocyte stasis in the capillaries, which develops during intoxication of any origin, leading to improved microcirculation. It enhances renal blood flow, increases glomerular filtration, and increases diuresis.
Pharmacokinetics
It is not metabolized in the body. It is rapidly excreted by the kidneys, 80% within 4 hours, and completely within 12-24 hours.
Indications
Shock (post-traumatic, postoperative, burn, hemorrhagic); intoxication (toxic diseases of the gastrointestinal tract, including dysentery, dyspepsia, salmonellosis; burn disease, radiation sickness and hemolytic disease, peritonitis, intestinal obstruction, thyrotoxicosis, liver diseases, sepsis, pneumonia; acute phase of myocardial infarction); toxemia of newborns; preeclampsia.
ICD codes
| ICD-10 code | Indication |
| A02 | Other salmonella infections |
| A03 | Shigellosis |
| A05 | Other bacterial food poisonings, not elsewhere classified |
| A09 | Other and unspecified gastroenteritis and colitis of infectious origin |
| A40 | Streptococcal sepsis |
| A41 | Other sepsis |
| B15 | Acute hepatitis A |
| B16 | Acute hepatitis B |
| B17 | Other acute viral hepatitis |
| B18 | Chronic viral hepatitis |
| E05 | Thyrotoxicosis [hyperthyroidism] |
| I21 | Acute myocardial infarction |
| J15 | Bacterial pneumonia, not elsewhere classified |
| K56.6 | Other and unspecified intestinal obstruction |
| K65.0 | Acute peritonitis (including abscess) |
| K70 | Alcoholic liver disease |
| K71 | Toxic liver disease |
| K73 | Chronic hepatitis, not elsewhere classified |
| K75 | Other inflammatory liver diseases |
| O10-O16 | Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the puerperium |
| P36 | Bacterial sepsis of newborn |
| P55 | Hemolytic disease of fetus and newborn |
| R54 | Acute intoxication |
| R57.0 | Cardiogenic shock |
| R57.1 | Hypovolemic shock |
| R57.2 | Septic shock |
| R57.8 | Other types of shock |
| T30 | Burns and corrosions of unspecified body region |
| T66 | Unspecified effects of radiation (radiation sickness) |
| T79.4 | Traumatic shock |
| ICD-11 code | Indication |
| 1A02 | Intestinal infections due to Shigella |
| 1A09.Z | Salmonella infection, unspecified |
| 1A1Z | Bacterial foodborne intoxications, unspecified |
| 1A40.Z | Infectious gastroenteritis or colitis, unspecified |
| 1E50.0 | Acute hepatitis A |
| 1E50.1 | Acute hepatitis B |
| 1E50.Z | Acute viral hepatitis, unspecified |
| 1E51.Z | Chronic viral hepatitis, unspecified |
| 1G40 | Sepsis without septic shock |
| 1G41 | Sepsis with septic shock |
| 4A85.00 | Drug hypersensitivity-induced liver disease |
| 5A02.Z | Thyrotoxicosis, unspecified |
| 8E61.0 | Radiation-induced brain injury |
| 8E61.1 | Radiation-induced spinal cord injury |
| BA41.Z | Acute myocardial infarction, unspecified |
| CA40.0Z | Bacterial pneumonia, unspecified |
| DA91.Z | Unspecified obstruction of small intestine |
| DB30.Z | Unspecified obstruction of large intestine |
| DB94.Z | Alcoholic liver disease, unspecified |
| DB95.Z | Drug-induced or toxic liver disease, unspecified |
| DB97.2 | Chronic hepatitis, not elsewhere classified |
| DB97.Z | Inflammatory liver diseases, unspecified |
| DC50.0 | Primary peritonitis |
| DC50.2 | Peritoneal abscess |
| DC50.Z | Peritonitis, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
| JA2Z | Edema, proteinuria, or hypertensive disorders in pregnancy, childbirth or the puerperium, unspecified |
| KA60 | Fetal or neonatal sepsis |
| KA84.Z | Hemolytic disease of fetus or newborn, unspecified |
| MG2A | Frailty syndrome |
| MG40.0 | Cardiogenic shock |
| MG40.1 | Hypovolemic shock |
| MG40.Z | Shock, unspecified |
| NE11 | Burn of unspecified body region |
| NF00 | Exposure to radiation, not elsewhere classified |
| NF0A.4 | Traumatic shock, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer intravenously by drip at a rate of 40-80 drops per minute.
Use an infusion set with an in-line filter and a polymer connection needle.
Determine the total dose based on the patient’s age and the severity of intoxication.
For adults, the typical single dose is 100 ml to 400 ml.
For pediatric patients, calculate the dose individually per body weight.
In cases of severe shock or profound intoxication, repeat infusions as clinically required.
Adjust the infusion rate to avoid a rapid drop in blood pressure or respiratory distress.
Do not exceed the recommended infusion speed.
Monitor blood pressure, heart rate, and respiratory function continuously during administration.
Discontinue the infusion immediately if signs of a hypersensitivity reaction occur.
The total daily volume and frequency of administration are determined by the treating physician.
Adverse Reactions
Possible decrease in blood pressure, tachycardia, difficulty breathing (with rapid administration), allergic reactions of varying severity (up to the development of anaphylactic shock); infection at the injection site, thrombosis or phlebitis spreading from the infusion site.
Contraindications
Intracranial hypertension; hemorrhagic stroke; condition after traumatic brain injury; chronic heart failure stage IIb-III; respiratory failure; severe allergic reactions; thromboembolism; oliguria, anuria, acute nephritis; bronchial asthma; phlebothrombosis; hypersensitivity to the components of the combination.
Use in Pregnancy and Lactation
The possibility of use depends on the dosage form used.
Use in Renal Impairment
Contraindicated in acute nephritis.
Pediatric Use
Use is possible according to the dosage regimen.
Special Precautions
During treatment, monitoring of blood pressure and the patient’s condition is necessary.
Drug Interactions
For extensive burns, it is combined with the administration of plasma, albumin, gamma globulin.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Arbidol, capsules 100mg, 40pcs
Cortexin, 10mg, 5ml, 10pcs
OKI, sachets 80mg 2g, 12pcs
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml
Cavinton Comfort, dispersible pills 10mg 90pcs
Picamilon pills 50mg, 60pcs
Ingavirin capsules 90mg, 10pcs
Nootropil pills 800mg, 30pcs
Belosalic, ointment, 30g
Mildronate capsules 500mg, 90pcs
Daivobet, ointment, 30g
Phenibut-Vertex pills 250mg, 20pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Kagocel pills 12mg, 30pcs 